The global radioactive tracer market is gaining momentum due to the increasing use of nuclear medicine in modern healthcare. Improvements in PET and SPECT technologies, expanding diagnostic infrastructure, and growing applications in oncology are contributing to market development. Continued investments in radiopharmaceutical research are expected to support further innovation. According to...